Sign up for our eNewsletter
[f] [t] [in] [blog]

Portfolio Companies

Bioscience
Clean Technology
Information Technology
Medical Device

Axerion Therapeutics Inc.

CEO: Sylvia McBrinn

Year Established: 2009

Description: Axerion Therapeutics, Inc. is a private, Connecticut-based biotechnology company focused on developing innovative therapeutics for neurological diseases and injuries with significant unmet medical need, including Alzheimer’s disease and spinal cord injury.

Web: http://www.axeriontherapeutics.com/

CI Representative:
David Wurzer
Executive Vice President and Chief Investment Officer

[photo]